VA-INTELSAT
22.11.2021 11:02:12 CET | Business Wire | Press release
Intelsat , operator of the world's largest integrated satellite and terrestrial network, announces the expansion of its global FlexMaritime service, now enabling connectivity for vessels traveling in Indian territorial waters and immediately enhancing the service coverage for all of Intelsat’s 8,000 existing FlexMaritime vessels. The landmark development also provides access for Indian-registered vessels to Intelsat’s award-winning global high-throughput maritime network. Intelsat's expansion is made possible by a new in-country gateway that is operationally ready to provide service via Intelsat’s HTS satellites under India-based partner Cloudcast 's In-Flight and Maritime Connectivity (IFMC) license.
FlexMaritime provides high-speed, resilient connectivity service with 99.95% proven network uptime. The expansion of FlexMaritime into India will open new business opportunities and accelerate digital transformation for thousands of Indian-flagged vessels and ships trading in Indian territorial waters. According to the Ministry of Shipping , around 95% of India's trading by volume and 70% by value is done through maritime transport.
"The completion of this regulatory milestone means customers of our FlexMaritime solutions partners will immediately benefit from the well-known power, performance and resilience of the FlexMaritime service in Indian waters," said Intelsat Senior Vice President of Mobility, Mark Rasmussen. "The network expansion also demonstrates Intelsat's commitment to mobility services providing yet another new dimension of global trade with access for Indian companies."
Intelsat has experienced continued growth in its FlexMaritime service. More than 8,000 vessels benefit from unrivaled network density and a global, multi-layered high-throughput satellite (HTS) fabric that enables partners to create unique service packages at enterprise-grade performance levels. With terminal sizes of 37cm, 45cm, 60cm and 1 meter, FlexMaritime meets the connectivity needs of every type of vessel with scale and global reach, even in high-traffic port locations.
The gateway will be located in Noida, India, serving as a critical link between Intelsat's terrestrial ground network and space assets and extending Intelsat's existing global network to a vital trading port.
Services are slated for availability at the beginning of 2022 through Intelsat's many solutions partners.
About Intelsat
As the foundational architects of satellite technology, Intelsat operates the world's most trusted satellite telecom network. We apply our unparalleled expertise and global scale to connect people, businesses and communities, no matter how difficult the challenge. Intelsat is building the future of global communications with the world's first hybrid, multi-orbit, software-defined 5G network designed for simple, seamless, and secure coverage precisely when and where our customers most need it. Follow the leader in global connectivity and "Imagine Here," with us, at Intelsat.com
.
About Cloudcast
Cloudcast is a 100% subsidiary of Planetcast Media Services Limited and is focused on growing the business in satellite communications and promoting excellence in Value Added Services, Business Practices, Technology and Operations. Cloudcast has commercial licenses for VSAT, ISP, and the new IFMC Gateway Services in India. Planetcast, the parent company, has over the years been instrumental in providing cutting-edge technology to enhance broadcast services. The Planetcast Group's ability to conceptualize, architect, and implement new and expanded capabilities allows clients to take their business to the next level. It is a key market player in providing technology-led managed services to the broadcasting industry in India.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211122005896/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom